These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 28992352
1. In vivo pathogenicity of Trichosporon asahii isolates with different in vitro enzymatic profiles in an immunocompetent murine model of systemic trichosporonosis. Montoya AM, Luna-Rodríguez CE, Treviño-Rangel RJ, Becerril-García M, Ballesteros-Elizondo RG, Saucedo-Cárdenas O, González GM. Med Mycol; 2018 Jun 01; 56(4):434-441. PubMed ID: 28992352 [Abstract] [Full Text] [Related]
3. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis. Treviño-Rangel Rde J, López LJ, Palma-Nicolás JP, Hernández-Bello R, González JG, González GM. J Antimicrob Chemother; 2014 Apr 01; 69(4):1075-8. PubMed ID: 24252752 [Abstract] [Full Text] [Related]
4. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients. Montoya AM, Elizondo-Zertuche M, Treviño-Rangel RJ, Becerril-García M, González GM. Rev Iberoam Micol; 2018 Apr 01; 35(1):22-26. PubMed ID: 29287630 [Abstract] [Full Text] [Related]
5. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. Sun W, Su J, Xu S, Yan D. J Med Microbiol; 2012 Dec 01; 61(Pt 12):1750-1757. PubMed ID: 22956749 [Abstract] [Full Text] [Related]
6. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis. Yang RY, Wang WL, Ao JH, Hao ZF, Zhang J, Wang CM. Chin Med J (Engl); 2008 Dec 20; 121(24):2557-60. PubMed ID: 19187595 [Abstract] [Full Text] [Related]
7. Cytokines profile in immunocompetent mice during Trichosporon asahii infection. Montoya AM, González GM, Martinez-Castilla AM, Aguilar SA, Franco-Molina MA, Coronado-Cerda E, Rosas-Taraco AG. Med Mycol; 2018 Jan 01; 56(1):103-109. PubMed ID: 28340200 [Abstract] [Full Text] [Related]
9. Antifungal Activity and Potential Action Mechanism of Allicin against Trichosporon asahii. Yang X, Bai S, Wu J, Fan Y, Zou Y, Xia Z, Ao J, Chen T, Zhang M, Yang R. Microbiol Spectr; 2023 Jun 15; 11(3):e0090723. PubMed ID: 37199655 [Abstract] [Full Text] [Related]
11. Experimental pathogenicity of a clinical isolate of Trichosporon dermatis in a murine model. Lin YP, Yang YP, Huang WM, Chen YH, Li SF, Fan YM. Mycopathologia; 2011 Nov 15; 172(5):381-7. PubMed ID: 21750940 [Abstract] [Full Text] [Related]
12. Disseminated trichosporonosis due to Trichosporon asahii in a diabetic patient. Negi V, Sharma M, Juyal D, Kotian S, Sharma N. Indian J Pathol Microbiol; 2015 Nov 15; 58(2):246-8. PubMed ID: 25885147 [Abstract] [Full Text] [Related]
13. The Cell Biology of the Trichosporon-Host Interaction. Duarte-Oliveira C, Rodrigues F, Gonçalves SM, Goldman GH, Carvalho A, Cunha C. Front Cell Infect Microbiol; 2017 Nov 15; 7():118. PubMed ID: 28439501 [Abstract] [Full Text] [Related]